dynavax.comDynavax Technologies | Toll-like Receptor | Vaccines
dynavax.com Profile
dynavax.com
Sub Domains:investors.dynavax.com
Title:Dynavax Technologies | Toll-like Receptor | Vaccines
Description:Dynavax Technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation.
Discover dynavax.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
dynavax.com Information
Website / Domain: |
dynavax.com |
HomePage size: | 21.44 KB |
Page Load Time: | 0.802787 Seconds |
Website IP Address: |
69.63.140.80 |
Isp Server: |
Edgewebhosting.net |
dynavax.com Ip Information
Ip Country: |
United States |
City Name: |
Baltimore |
Latitude: |
39.294605255127 |
Longitude: |
-76.623489379883 |
dynavax.com Keywords accounting
dynavax.com Httpheader
Date: Sat, 04 Apr 2020 02:07:37 GMT |
Server: Apache |
X-Frame-Options: SAMEORIGIN |
Vary: User-Agent,Accept-Encoding |
ETag: 35iuf3 |
Cache-Control: max-age=30, s-maxage=30 |
Expires: Sat, 04 Apr 2020 02:09:38 GMT |
Content-Encoding: gzip |
Content-Length: 2798 |
Keep-Alive: timeout=5, max=100 |
Connection: Keep-Alive |
Content-Type: text/html;charset=UTF-8 |
dynavax.com Meta Info
content="text/html; charset=utf-8" http-equiv="Content-Type"/ |
content="Dynavax Technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation." name="description"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
content="IE=edge" http-equiv="X-UA-Compatible"/ |
69.63.140.80 Domains
dynavax.com Similar Website
Domain |
WebSite Title |
dynavax.com | Dynavax Technologies | Toll-like Receptor | Vaccines |
investors.dynavax.com | Investor Relations | Dynavax Technologies Corporation |
dynavax.com Traffic Sources Chart
dynavax.com Alexa Rank History Chart
dynavax.com Html To Plain Text
Protection for an unpredictable world We are developing cutting-edge vaccines by utilizing our innovative adjuvant technology and our expertise of Toll-like Receptor (TLR) biology to modulate the immune system. TLR Biology HEPLISAV-B® [HEPATITIS B VACCINE (RECOMBINANT) ADJUVANTED] Focusing on Developing Innovative Vaccines Utilizing innovative adjuvant technology, Dynavax is leveraging Toll-like receptor (TLR) biology to stimulate the innate immune system to trigger a specific adaptive immune response to specific disease antigens for improved vaccines. Learn more about our Product Recent News Apr 02, 2020 Dynavax Provides Business Update on COVID-19 Pandemic Impact Mar 26, 2020 Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19) View All News About Overview Management Board of Directors Dynavax Europe Product HEPLISAV-B Science Overview Publications & Presentations Ongoing Studies Overview Ongoing Studies Listing Partnership Investors & Media Overview Press Releases Events & Presentations Stock Information Analyst Coverage Financials SEC Filings Annuals and Proxies Corporate Governance and Compliance Board of Directors Committee Composition Contact the Board Contact Us Careers Join Our Team Job Opportunities Benefits Contact Home About Overview Management Board of Directors Dynavax Europe Product HEPLISAV-B Science Overview Publications & Presentations Ongoing Studies Overview Ongoing Studies Listing Partnership Investors & Media Overview Press Releases Events & Presentations Stock Information Analyst Coverage Financials SEC Filings Annuals and Proxies Corporate Governance and Compliance Board of Directors Committee Composition Contact the Board Contact Us Careers Join Our Team Job Opportunities Benefits Contact Terms of Use Privacy Notice © 2020 Dynavax Technologies. All rights reserved. Terms of Use Privacy Notice Website Design : Hane Chow, Inc. US-19-00-00200...
dynavax.com Whois
"domain_name": "DYNAVAX.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": [
"2020-03-24 05:15:45",
"2018-12-10 07:41:04"
],
"creation_date": "1997-02-07 05:00:00",
"expiration_date": "2022-02-08 05:00:00",
"name_servers": [
"NS-1111.AWSDNS-10.ORG",
"NS-1605.AWSDNS-08.CO.UK",
"NS-444.AWSDNS-55.COM",
"NS-605.AWSDNS-11.NET"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": [
"abuse@web.com",
"sconover@dynavax.com"
],
"dnssec": "unsigned",
"name": "Dynavax Technologies",
"org": "Dynavax Technologies",
"address": "2100 POWELL ST STE 900",
"city": "Emeryville",
"state": "CA",
"zipcode": "94608-1844",
"country": "US"